Contingency Management for Stimulant Use Disorder Progress, Challenges, and Recommendations

被引:14
|
作者
Rawson, Richard A. [1 ,2 ,4 ]
Erath, Tyler G. [1 ,2 ,5 ]
Chalk, Mady [1 ]
Clark, H. Westley [1 ]
McDaid, Carol [1 ]
Wattenberg, Sarah A. [1 ]
Roll, John M. [1 ,3 ]
McDonell, Michael G. [3 ]
Parent, Sara [3 ]
Freese, Thomas E. [4 ]
机构
[1] Univ Vermont, Motivat Incent Policy Grp, Burlington, VT USA
[2] Univ Vermont, Vermont Ctr Behav & Hlth, Dept Psychiat, Burlington, VT USA
[3] Washington State Univ, Coll Med, Community & Behav Hlth Dept, Pullman, WA USA
[4] UCLA, Integrated Subst Abuse Programs, Los Angeles, CA USA
[5] Univ Vermont, Univ Hlth Ctr, Vermont Ctr Behav & Hlth, 1 S Prospect St, Burlington, VT 05401 USA
来源
JOURNAL OF AMBULATORY CARE MANAGEMENT | 2023年 / 46卷 / 02期
关键词
cocaine; contingency management; dissemination; implementation; incentives; methamphetamine; reinforcement; stimulant use disorder; SUBSTANCE USE;
D O I
10.1097/JAC.0000000000000450
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The United States is currently in the fourth wave of the overdose crisis wherein stimulants together with fentanyl are the major drivers of overdose deaths. To date, there has been limited effort outside the US Veterans Administration Health System health system to disseminate evidence-based treatment for people with stimulant use disorder. Contingency management, a behavioral intervention in which positive reinforcement is provided for a target behavior indicating treatment progress, has decades of empirical support but limited implementation in real-world, non-US Veterans Administration Health System settings. The purpose of the report is to provide an overview of contingency management, the barriers to adoption, and recommendations for overcoming these barriers.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 50 条
  • [21] Contingency management for the treatment of methamphetamine use disorder: A systematic review
    Brown, Hayley D.
    DeFulio, Anthony
    DRUG AND ALCOHOL DEPENDENCE, 2020, 216
  • [22] Challenges and Possible Solutions for Implementing Contingency Management for Adolescent Substance Use Disorder in Community-Based Settings
    Randall, Jeff
    JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE, 2017, 26 (04) : 332 - 337
  • [23] Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research
    Stoops, William W.
    Rush, Craig R.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (03) : 363 - 374
  • [25] Contingency Management for Patients With Serious Mental Illness and Stimulant Dependence
    Weiss, Roger D.
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (01): : 6 - 8
  • [26] Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder
    Wardle, Margaret C.
    Vincent, Jessica N.
    Suchting, Robert
    Green, Charles E.
    Lane, Scott D.
    Schmitz, Joy M.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2017, 72 : 32 - 39
  • [27] Contingency Management Programs Show Promise In Treatment of Cocaine Use Disorder
    Shah, Kishan
    Lazar, Dawid
    Tong, Chun
    Noureddine, Chaden
    AMERICAN JOURNAL ON ADDICTIONS, 2022, 31 (04): : 294 - 294
  • [28] The Efficacy of Contingency Management for Adolescent Cannabis Use Disorder: A Controlled Study
    Kaminer, Yifrah
    Burleson, Joseph A.
    Burke, Rebecca
    Litt, Mark D.
    SUBSTANCE ABUSE, 2014, 35 (04) : 391 - 398
  • [29] CHARACTERISTICS OF STIMULANT USE AND STIMULANT USE DISORDER AMONG CANADIAN UNIVERSITY STUDENTS
    Clarke, Quinten
    Wang, Angel
    Paz, Priscilla
    Vigo, Daniel
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2023, 30 : S86 - S87
  • [30] EFFICACY AND TOLERABILITY OF CONTINGENCY MANAGEMENT AND COGNITIVE-BEHAVIORAL THERAPY WITH PHARMACOTHERAPY OR PLACEBO IN MANAGING STIMULANT USE DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Eze, U.
    Ologunowa, A.
    Ozota, O.
    Ufuah, U.
    Oguguo, V
    Onyia, I
    Sabastine, R.
    Ifeanyi, R.
    Salim, J.
    Obi, O.
    Asogwa, C.
    Ononuju, U.
    Ben-Umeh, K.
    Amorha, K.
    VALUE IN HEALTH, 2024, 27 (06) : S405 - S405